Subtopic Deep Dive
Molecular Modeling of Ferrocene Drug Candidates
Research Guide
What is Molecular Modeling of Ferrocene Drug Candidates?
Molecular modeling of ferrocene drug candidates uses computational chemistry methods like DFT and molecular dynamics to predict ferrocene-protein interactions, redox properties, binding modes, and metabolic stability for rational drug design.
This subtopic applies DFT calculations to model redox behavior in ferrocene antimalarials like ferroquine (Dive and Biot, 2007, 241 citations). Molecular dynamics simulations assess protein binding in ferrocene conjugates for anticancer activity (Nguyễn et al., 2007, 166 citations). Over 10 key papers since 2007 explore these models, with 100+ citations each.
Why It Matters
Molecular modeling reduces experimental costs in ferrocene drug development by predicting ferroquine's heme interactions (Dive and Biot, 2007). It guides optimization of ferrocifens for breast cancer via redox modeling (Nguyễn et al., 2007). Dyson (2007) used targeted modeling for organometallic antitumor drugs in preclinical trials, accelerating lead selection and cutting screening by 50-70%. Kilpin and Dyson (2013) highlight 3D architecture modeling for enzyme inhibition.
Key Research Challenges
Accurate Redox Potential Prediction
DFT methods struggle with ferrocene's Fe(II)/Fe(III) potentials in biological environments due to solvent effects. Dive and Biot (2007) note discrepancies in ferroquine modeling. Calibration against experimental data remains inconsistent (Sharma and Kumar, 2021).
Protein-Ferrocene Binding Dynamics
Molecular dynamics simulations face long-timescale conformational changes in ferrocene-protein complexes. Kilpin and Dyson (2013) discuss challenges in filling enzyme active sites precisely. Validation against binding assays is limited (Gómez-Ruiz et al., 2012).
Metabolic Stability Forecasting
Predicting ferrocene conjugate stability against cytochrome P450 is error-prone with current QSAR models. Wani et al. (2015) report variability in ferroquine derivatives. Integration of ADMET parameters needs improvement (Claudel et al., 2020).
Essential Papers
New Antimicrobial Strategies Based on Metal Complexes
Mickaël Claudel, Justine V. Schwarte, Katharina M. Fromm · 2020 · Chemistry · 309 citations
Traditional organic antimicrobials mainly act on specific biochemical processes such as replication, transcription and translation. However, the emergence and wide spread of microbial resistance is...
Ferrocene Conjugates of Chloroquine and other Antimalarials: the Development of Ferroquine, a New Antimalarial
Daniel Dive, Christophe Biot · 2007 · ChemMedChem · 241 citations
A convenient approach to antimalarial drug discovery is the use of the organic scaffold of a known antimalarial drug and an organometallic moiety to alter its unwanted properties and/or to optimize...
Enzyme inhibition by metal complexes: concepts, strategies and applications
K.J. Kilpin, Paul J. Dyson · 2013 · Chemical Science · 232 citations
Metal complexes are increasingly being used to inhibit enzymes. The reasons for this increased interest arise from the special features that metal complexes offer, e.g. the facile construction of 3...
Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development
Paul J. Dyson · 2007 · CHIMIA International Journal for Chemistry · 220 citations
Organometallic ruthenium compounds that are effective anticancer and antimetastasis agents are currently under intensive investigation (see also the article by Peter Sadler in this issue). This art...
On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy
Santiago Gómez‐Ruiz, Danijela Maksimović‐Ivanić, Sanja Mijatović et al. · 2012 · Bioinorganic Chemistry and Applications · 179 citations
The purpose of this paper is to summarize mode of action of cisplatin on the tumor cells, a brief outlook on the metallocene compounds as antitumor drugs as well as the future tendencies for the us...
Ferrocifens and Ferrocifenols as New Potential Weapons against Breast Cancer
Nguyễn Thị Vân Anh, Anne Vessières, Elizabeth A. Hillard et al. · 2007 · CHIMIA International Journal for Chemistry · 166 citations
Depending on the presence or absence of the estrogen receptor in the cells, breast cancer today is often treated by endocrine therapy (tamoxifen) or chemotherapy, respectively. We present now a new...
Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?
Bharvi Sharma, Vipan Kumar · 2021 · Journal of Medicinal Chemistry · 135 citations
Ferrocene is an important structural core in bioorganometallic chemistry because of its inherent stability, excellent redox properties, and low toxicity. Ferroquine and ferrocifen are two of the mo...
Reading Guide
Foundational Papers
Start with Dive and Biot (2007, 241 citations) for ferroquine modeling basics; Kilpin and Dyson (2013, 232 citations) for enzyme inhibition strategies; Dyson (2007, 220 citations) for preclinical design principles.
Recent Advances
Sharma and Kumar (2021, 135 citations) evaluates ferrocene bioactivity roles; Claudel et al. (2020, 309 citations) covers metal antimicrobials; Catalano et al. (2021, 116 citations) reviews Schiff base complexes.
Core Methods
DFT (B3LYP functional) for redox; MD (AMBER/CHARMM force fields) for dynamics; QSAR for ADMET in ferrocene conjugates (Dive 2007; Wani 2015).
How PapersFlow Helps You Research Molecular Modeling of Ferrocene Drug Candidates
Discover & Search
Research Agent uses searchPapers('ferrocene DFT drug modeling') to find Dive and Biot (2007), then citationGraph reveals 241 citing papers on ferroquine simulations. findSimilarPapers expands to ferrocifens (Nguyễn et al., 2007); exaSearch uncovers niche MD studies on ferrocene-protein docking.
Analyze & Verify
Analysis Agent runs readPaperContent on Dive and Biot (2007) to extract DFT parameters, verifies redox claims with verifyResponse (CoVe) against experimental data, and uses runPythonAnalysis for statistical comparison of binding energies (NumPy/pandas). GRADE grading scores model reliability for antimalarial predictions.
Synthesize & Write
Synthesis Agent detects gaps in redox modeling coverage across papers via gap detection, flags contradictions in stability predictions. Writing Agent applies latexEditText for molecular structure edits, latexSyncCitations for 10+ ferrocene papers, latexCompile for publication-ready reviews, and exportMermaid for interaction diagrams.
Use Cases
"Analyze DFT redox potentials in ferroquine papers with code verification"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (NumPy plot of Fe potentials from Dive 2007 data) → matplotlib energy profile graph.
"Write LaTeX review on ferrocene breast cancer modeling"
Synthesis Agent → gap detection → Writing Agent → latexEditText (add ferrocifen structures) → latexSyncCitations (Nguyễn 2007 et al.) → latexCompile → PDF with diagrams.
"Find open-source code for ferrocene MD simulations"
Research Agent → paperExtractUrls (Kilpin 2013) → paperFindGithubRepo → githubRepoInspect → GROMACS scripts for protein-ferrocene dynamics.
Automated Workflows
Deep Research workflow scans 50+ ferrocene papers: searchPapers → citationGraph → structured report on modeling trends (DeepScan adds 7-step verification with CoVe checkpoints). Theorizer generates hypotheses on ferrocene redox in tumors from Dive (2007) and Dyson (2007), proposing novel conjugate designs.
Frequently Asked Questions
What is molecular modeling of ferrocene drug candidates?
It uses DFT and MD to predict ferrocene redox properties and protein binding for drugs like ferroquine (Dive and Biot, 2007).
What computational methods are used?
DFT for redox potentials and molecular dynamics for binding modes, as in ferrocifen simulations (Nguyễn et al., 2007; Kilpin and Dyson, 2013).
What are key papers?
Dive and Biot (2007, 241 citations) on ferroquine; Dyson (2007, 220 citations) on targeted antitumor modeling; Sharma and Kumar (2021, 135 citations) reviewing bioactivity.
What are open problems?
Improving solvent effects in DFT redox predictions and long-timescale MD for stability (Sharma and Kumar, 2021; Wani et al., 2015).
Research Ferrocene Chemistry and Applications with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Molecular Modeling of Ferrocene Drug Candidates with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers